BIOLASE Technology, Inc. (NASDAQ: BLTI), the World's leading dental laser manufacturer and distributor, today announced that Vice President, International, William E. Brown has been promoted to Vice President, Sales & Marketing, effective immediately. In this position, Brown will report directly to Federico Pignatelli, Chairman and Chief Executive Officer.

Brown, 64, has more than 30 years of experience in global medical/dental companies, with an emphasis in lasers. He joined the marketing department of BIOLASE in 2002 and has held increasingly responsible positions. As Vice President, International, he was responsible for all international sales and distribution, including the implementation of new sales and marketing strategies and tactics across the Company's international dental markets, and has been involved in business development activities since late 2010.

Pignatelli said, "Bill has been an integral part of our management team and has played a critical role in the restructuring and relaunch of BIOLASE. He has a proven track record, great dedication and an in-depth understanding of the global dental laser market and the needs of our customers and distributors. This knowledge and expertise will be instrumental as we introduce new market-leading products in our drive to become the Total Technology Solution for the dental community."

Brown commented, "This is an exciting time at BIOLASE. We have world-class products and the largest specialized sales force and distribution network in the area. There are many marketing opportunities for our patented technology in dentistry, ophthalmology and other medical specialties. I believe we are well positioned to take advantage of these opportunities and continue the strong sales momentum from 2011 into this year."

Brown was a co-founder of Kreativ, Inc., an international high tech dental equipment company, where he served from 1995 to 1999. Following the acquisition in 1999 by Welch-Allyn, Inc., he served as Director of New Product Development for Welch-Allyn Kreativ and member of the Board of Directors until 2002. Prior to this, he spent five years with HGM Medical Laser Systems, Inc., an international medical laser manufacturer, as Vice President of Sales and Marketing on a global basis.

Brown is on the Board of Directors of the World Congress of Minimally Invasive Dentistry, Executive Director of the World Clinical Laser Institute (WCLI), Fellow of the American Society for Laser Medicine & Surgery (ASLMS), Member of SPIE, Biomedical Optics Society, and the Academy of Laser Dentistry.

Brown holds a Bachelor's degree in Electrical Engineering from the University of Alabama.

About BIOLASE Technology, Inc. BIOLASE Technology, Inc., the World's leading Dental Laser Company, is a medical technology company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment, products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate 284 patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 19,000 lasers among 16,000 customers. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on laser and Waterlase dentistry, find BIOLASE at http://www.biolase.com, Twitter at http://twitter.com/GoWaterlase, and YouTube at http://www.youtube.com/user/Rossca08.

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

For further information, please contact: Jill Bertotti of Allen & Caron +1-949-474-4300

Biolase (NASDAQ:BLTI)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Biolase Charts.
Biolase (NASDAQ:BLTI)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Biolase Charts.